The SYNE1 gene plays a crucial role in Emery-Dreifuss Muscular Dystrophy type 4 (EDMD4), a condition characterized by muscle weakness, contractures, and cardiac abnormalities. Testing for mutations in the SYNE1 gene is critical for the diagnosis and management of EDMD4. DNA Labs UAE offers a genetic test specifically designed to detect mutations in the SYNE1 gene, providing essential information for patients and their families regarding prognosis, treatment options, and genetic counseling. The cost of this comprehensive test is 4400 AED. Conducted in a state-of-the-art laboratory setting, the test ensures accuracy and reliability, offering valuable insights into this rare genetic disorder.
The SYNE2 Gene Emery-Dreifuss Muscular Dystrophy Type 5 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the SYNE2 gene that are associated with Emery-Dreifuss Muscular Dystrophy (EDMD) type 5. This condition is a rare form of muscular dystrophy characterized by muscle weakness and wasting, joint contractures, and heart problems, which can vary in severity among affected individuals. The genetic test involves analyzing the patient's DNA to identify mutations in the SYNE2 gene, which play a crucial role in the structural integrity and function of muscle and heart cells. Early detection through this test can aid in the management and treatment of the condition, potentially improving the quality of life for those affected. The test is priced at 4400 AED and is conducted with high precision and confidentiality at DNA Labs UAE, ensuring patients receive accurate and timely results.
Emery-Dreifuss muscular dystrophy type 6 (EDMD6) is a rare genetic condition characterized by muscle weakness and wasting, joint contractures, and cardiac abnormalities. This condition is caused by mutations in the FHL1 gene, which plays a crucial role in muscle development and function. Identifying mutations in the FHL1 gene is essential for diagnosing EDMD6, assessing the risk of passing the condition to offspring, and guiding treatment and management decisions.
DNA Labs UAE offers a genetic test specifically designed to detect mutations in the FHL1 gene associated with Emery-Dreifuss muscular dystrophy type 6. This test is a vital tool for individuals with a family history of EDMD6 or those presenting symptoms suggestive of the condition. The genetic test involves analyzing the patient's DNA, extracted from a blood sample, to identify any mutations in the FHL1 gene.
The cost of the FHL1 gene test for Emery-Dreifuss muscular dystrophy type 6 at DNA Labs UAE is 4400 AED. This price includes the collection of the sample, the genetic analysis, and a comprehensive report detailing the results and their implications for the patient's health and family planning. Patients considering this test are encouraged to discuss it with their healthcare provider to understand its benefits and limitations fully.
The SLC13A5 gene plays a crucial role in the human body, particularly in the transport of citrate across cell membranes. Mutations in this gene can lead to a rare neurological condition known as Early Infantile Epileptic Encephalopathy Type 25 (EIEE25). This condition is characterized by frequent seizures that begin in the first days of life, developmental delay, and other neurological issues. Given the severity and rarity of EIEE25, accurate diagnosis is critical for managing the condition and providing appropriate care and support to affected individuals and their families.
DNA Labs UAE offers a genetic test specifically designed to identify mutations in the SLC13A5 gene, which is pivotal for diagnosing EIEE25. This test involves analyzing the patient's DNA to look for abnormalities in the SLC13A5 gene that are known to cause the condition. The cost of the test is 4400 AED, a price that reflects the specialized nature of the analysis and the profound impact that a precise diagnosis can have on treatment plans and quality of life for affected individuals.
Opting for this test at DNA Labs UAE provides patients and healthcare providers with crucial information that can lead to a better understanding of the condition, enabling tailored treatment approaches, and offering insights into potential genetic counseling for families. The lab's expertise in genetic diagnostics ensures a high level of accuracy and reliability in the test results, making it a valuable resource for those dealing with the challenges of EIEE25.
The KCNB1 gene plays a crucial role in the proper functioning of the nervous system, and mutations in this gene are associated with early infantile epileptic encephalopathy type 26 (EIEE26). This condition is characterized by frequent seizures that begin in infancy, along with various degrees of developmental delay and sometimes additional neurological symptoms. Given the significant impact this condition can have on affected individuals and their families, genetic testing for mutations in the KCNB1 gene is an important diagnostic tool.
DNA Labs UAE offers a specialized genetic test aimed at identifying mutations within the KCNB1 gene to confirm a diagnosis of early infantile epileptic encephalopathy type 26. This test is crucial for affected families, as it not only aids in the diagnosis but also helps in guiding treatment decisions and understanding the prognosis. Furthermore, it can provide valuable information for genetic counseling, particularly for family planning and assessing the risk of recurrence in future pregnancies.
The test cost is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to accurately interpret the results. Conducted in a state-of-the-art laboratory by professionals skilled in genetic diagnostics, this test represents a significant step forward for families seeking answers in the face of challenging neurological conditions.
The GRIN2B gene is crucial for normal brain function, playing a key role in the development of the nervous system and synaptic plasticity. Mutations in this gene have been linked to early infantile epileptic encephalopathy type 27 (EIEE27), a severe condition characterized by frequent seizures, developmental delays, and various neurological issues beginning in infancy.
DNA Labs UAE offers a specialized genetic test designed to identify mutations in the GRIN2B gene associated with EIEE27. This test is an important tool for diagnosing the condition, enabling early intervention and personalized treatment plans to manage symptoms and improve quality of life for affected individuals.
The cost of the GRIN2B Gene Early Infantile Epileptic Encephalopathy Type 27 Genetic Test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the lab to detect any genetic abnormalities in the GRIN2B gene. Results from this test can provide crucial information for families and healthcare providers, guiding decisions about care and support for individuals with EIEE27.
The WWOX gene plays a significant role in early infantile epileptic encephalopathy type 28 (EIEE28), a condition characterized by severe seizures and developmental delays in infancy. Genetic testing for mutations in the WWOX gene is crucial for the diagnosis and management of EIEE28. DNA Labs UAE offers a specialized genetic test to identify these mutations, providing essential information for families and healthcare providers. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect abnormalities in the WWOX gene that may be responsible for the condition. This genetic testing is a vital step towards understanding the specific cause of the epilepsy and encephalopathy, allowing for tailored treatment plans and support for affected individuals and their families.
The AARS1 gene plays a crucial role in the proper functioning of the human body by coding for alanyl-tRNA synthetase, an enzyme involved in protein synthesis. Mutations in this gene have been linked to early infantile epileptic encephalopathy type 29 (EIEE29), a severe form of epilepsy that manifests in the first few months of life. This condition is characterized by frequent seizures, developmental delays, and, in many cases, other neurological impairments.
To diagnose this condition accurately and early, genetic testing targeting the AARS1 gene can be performed. DNA Labs UAE offers a specialized genetic test for EIEE29, providing a crucial diagnostic tool for affected families. The test involves analyzing the patient's DNA to identify mutations in the AARS1 gene that are known to cause the disorder. This information can aid in the development of a tailored treatment plan, potentially improving outcomes for the affected individual.
The cost of the AARS1 Gene Early Infantile Epileptic Encephalopathy Type 29 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the specific genetic alterations associated with this condition, offering invaluable insights for affected families and their healthcare providers.
The SLC25A22 gene is associated with early infantile epileptic encephalopathy type 3 (EIEE3), a severe form of epilepsy that begins in infancy. This condition is characterized by frequent seizures and significant neurodevelopmental delay. The SLC25A22 gene plays a crucial role in the proper functioning of mitochondria, the energy-producing components of cells, and mutations in this gene can disrupt brain activity, leading to the symptoms observed in EIEE3.
Genetic testing for mutations in the SLC25A22 gene is a critical step in diagnosing EIEE3, enabling early intervention and tailored management plans for affected infants. DNA Labs UAE offers a comprehensive genetic test for the SLC25A22 gene to help identify the presence of mutations associated with early infantile epileptic encephalopathy type 3. The test cost is 3200 AED and is conducted with state-of-the-art technology to ensure accurate and reliable results. By undergoing this test, families can gain valuable insights into the genetic underpinnings of the condition, which can inform treatment decisions and provide a clearer prognosis for affected infants.
The SIK1 gene plays a crucial role in the development and function of the nervous system. Mutations in this gene have been associated with Early Infantile Epileptic Encephalopathy Type 30 (EIEE30), a severe form of epilepsy that emerges in the first few months of life. This condition is characterized by frequent seizures and significant developmental delays, presenting a profound challenge for affected individuals and their families.
DNA Labs UAE offers a specialized genetic test to identify mutations in the SIK1 gene, providing crucial information for the diagnosis of EIEE30. The test is an important tool for clinicians in confirming the diagnosis, which can then guide treatment strategies and genetic counseling. Understanding the genetic basis of the condition can also help in predicting the course of the disease and in some cases, may inform treatment options.
The cost of the SIK1 gene test for Early Infantile Epileptic Encephalopathy Type 30 at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect mutations in the SIK1 gene, providing families and healthcare providers with essential information for managing the condition. Given the complexity of EIEE30 and the significant impact it has on affected individuals, this genetic test represents a critical step in the journey towards better care and outcomes.
